165 related articles for article (PubMed ID: 3632710)
1. Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds.
Lyles GA; Marshall CM; McDonald IA; Bey P; Palfreyman MG
Biochem Pharmacol; 1987 Sep; 36(17):2847-53. PubMed ID: 3632710
[TBL] [Abstract][Full Text] [Related]
2. An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase.
Lyles GA; Fitzpatrick CM
J Pharm Pharmacol; 1985 May; 37(5):329-35. PubMed ID: 2862241
[TBL] [Abstract][Full Text] [Related]
3. Semicarbazide-sensitive amine oxidase (SSAO) of the rat aorta. Interactions with some naturally occurring amines and their structural analogues.
Elliott J; Callingham BA; Sharman DF
Biochem Pharmacol; 1989 May; 38(9):1507-15. PubMed ID: 2719723
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.
Eriksson M; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):273-8. PubMed ID: 6514011
[TBL] [Abstract][Full Text] [Related]
5. Comparative ex vivo inhibitory effects of (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat.
Lyles GA; Marshall CM; Flucker CJ
Biochem Pharmacol; 1989 Sep; 38(17):2937-40. PubMed ID: 2775316
[No Abstract] [Full Text] [Related]
6. Aminoacetone metabolism by semicarbazide-sensitive amine oxidase in rat aorta.
Lyles GA; Chalmers J
Biochem Pharmacol; 1995 Jan; 49(3):416-9. PubMed ID: 7857329
[TBL] [Abstract][Full Text] [Related]
7. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.
Precious E; Gunn CE; Lyles GA
Biochem Pharmacol; 1988 Feb; 37(4):707-13. PubMed ID: 3342102
[TBL] [Abstract][Full Text] [Related]
8. Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential.
Palfreyman MG; McDonald IA; Bey P; Danzin C; Zreika M; Cremer G
J Neural Transm Suppl; 1994; 41():407-14. PubMed ID: 7931257
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species.
Yu PH; Zuo DM
Biochem Pharmacol; 1992 Jan; 43(2):307-12. PubMed ID: 1739419
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).
Fowler CJ; Eriksson M; Thorell G; Magnusson O
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):279-84. PubMed ID: 6514012
[TBL] [Abstract][Full Text] [Related]
11. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
[TBL] [Abstract][Full Text] [Related]
12. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
Elliott J; Callingham BA; Barrand MA
J Pharm Pharmacol; 1989 Jan; 41(1):37-41. PubMed ID: 2565962
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.
Kinemuchi H; Kobayashi N; Takahashi K; Takayanagi K; Arai Y; Tadano T; Kisara K; Oreland L
Arch Biochem Biophys; 2001 Jan; 385(1):154-61. PubMed ID: 11361012
[TBL] [Abstract][Full Text] [Related]
14. Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta.
Lyles GA; Singh I
J Pharm Pharmacol; 1985 Sep; 37(9):637-43. PubMed ID: 2867184
[TBL] [Abstract][Full Text] [Related]
15. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity.
Yu PH; Zuo DM; Davis BA
Biochem Pharmacol; 1994 Mar; 47(6):1055-9. PubMed ID: 8147904
[TBL] [Abstract][Full Text] [Related]
18. The ex vivo effects of procarbazine and methylhydrazine on some rat amine oxidase activities.
Holt A; Callingham BA
J Neural Transm Suppl; 1994; 41():439-43. PubMed ID: 7931263
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
Holt A; Todd KG; Baker GB
Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
[TBL] [Abstract][Full Text] [Related]
20. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
Pino R; Lyles GA
Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
